Boston Ocular Surface Prosthesis for persistent epitheliopathy after treatment of conjunctival melanoma

Cornea. 2010 Apr;29(4):459-61. doi: 10.1097/ICO.0b013e3181b55b40.

Abstract

Purpose: To report two cases of persistent epitheliopathy after treatment of conjunctival melanoma and review management options for this condition.

Methods: Case report and literature review.

Results: Persistent epitheliopathy, presumably resulting from limbal stem cell deficiency, is an uncommon complication of treatment of conjunctival malignant melanoma with surgical excision, cryotherapy, and mitomycin C. The Boston Ocular Surface Prosthesis was successful in improving vision, comfort, and epithelial status in our patients.

Conclusion: Persistent epitheliopathy is a rare complication of treatment of conjunctival melanoma. The Boston Ocular Surface Prosthesis is a viable treatment option in this situation.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Alkylating Agents / administration & dosage
  • Artificial Organs
  • Conjunctival Neoplasms / pathology
  • Conjunctival Neoplasms / surgery*
  • Corneal Diseases / etiology
  • Corneal Diseases / surgery*
  • Epithelium, Corneal / pathology
  • Epithelium, Corneal / surgery*
  • Female
  • Humans
  • Male
  • Melanoma / pathology
  • Melanoma / surgery*
  • Middle Aged
  • Mitomycin / administration & dosage
  • Postoperative Complications*
  • Prostheses and Implants*
  • Prosthesis Implantation*

Substances

  • Alkylating Agents
  • Mitomycin